220 related articles for article (PubMed ID: 36579321)
1. Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX.
Fajber K
Health Hum Rights; 2022 Dec; 24(2):219-228. PubMed ID: 36579321
[TBL] [Abstract][Full Text] [Related]
2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
Eccleston-Turner M; Upton H
Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
[TBL] [Abstract][Full Text] [Related]
3. Risky business: COVAX and the financialization of global vaccine equity.
Stein F
Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
[TBL] [Abstract][Full Text] [Related]
4. COVAX, vaccine donations and the politics of global vaccine inequity.
de Bengy Puyvallée A; Storeng KT
Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
[TBL] [Abstract][Full Text] [Related]
5. COVAX and equitable access to COVID-19 vaccines.
Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
[TBL] [Abstract][Full Text] [Related]
6. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic.
Altindis E
Expert Rev Vaccines; 2022 Apr; 21(4):427-430. PubMed ID: 34878957
[No Abstract] [Full Text] [Related]
7. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
[TBL] [Abstract][Full Text] [Related]
8. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
[TBL] [Abstract][Full Text] [Related]
9. A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review.
Pushkaran A; Chattu VK; Narayanan P
BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37793808
[TBL] [Abstract][Full Text] [Related]
10. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
[No Abstract] [Full Text] [Related]
11. Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews.
Gorodensky A; Grundy Q; Persaud N; Kohler JC
J Glob Health; 2023 Dec; 13():04165. PubMed ID: 38063440
[TBL] [Abstract][Full Text] [Related]
12. Charity or empowerment? The role of COVAX for low and middle-income countries.
Holzer F; Roa TM; Germani F; Biller-Andorno N; Luna F
Dev World Bioeth; 2023 Mar; 23(1):59-66. PubMed ID: 35307947
[TBL] [Abstract][Full Text] [Related]
13. The Race for Global Equitable Access to COVID-19 Vaccines.
Md Khairi LNH; Fahrni ML; Lazzarino AI
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
[TBL] [Abstract][Full Text] [Related]
14. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
Lie RK; Miller FG
Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
[TBL] [Abstract][Full Text] [Related]
15. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap.
Forman L; Jackson C; Fajber K
Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686
[TBL] [Abstract][Full Text] [Related]
16. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap.
Borges LC; Zeferino de Menezes H; Crosbie E
Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975
[TBL] [Abstract][Full Text] [Related]
17. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
Bai AY; Zhang B; Jiang Y; Qiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
[TBL] [Abstract][Full Text] [Related]
18. WHO's allocation framework for COVAX: is it fair?
Sharma S; Kawa N; Gomber A
J Med Ethics; 2022 Jul; 48(7):434-438. PubMed ID: 33837046
[TBL] [Abstract][Full Text] [Related]
19. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
Louden EM
Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
Geiger S; McMahon A
J Med Ethics; 2023 Aug; 49(8):583-590. PubMed ID: 34848492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
